|
業務類別
|
Medical Devices |
|
業務概覽
|
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world. |
| 公司地址
| 20 Eastbourne Terrace, London, GBR, W2 6LG |
| 電話號碼
| +44 2033250660 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.livanova.com |
| 員工數量
| 3300 |
| Mr. Alex Shvartsburg |
Chief Financial Officer and Principal Accounting Officer |
美元 587.77K |
29/04/2026 |
| Mr. Vladimir A. Makatsaria |
Chief Executive Officer and Director |
美元 956.12K |
29/04/2026 |
| Ms. Stephanie Bolton |
President, Global Epilepsy |
-- |
29/04/2026 |
| Ms. Natalia Kozmina |
Chief Human Resources Officer |
美元 496.63K |
29/04/2026 |
| Dr. Ahmet Tezel, PhD |
Chief Innovation Officer |
美元 564.81K |
29/04/2026 |
| Mr. Franco Poletti |
President, Cardiopulmonary |
-- |
29/04/2026 |
|
|
| Mr. Donald J. Zurbay |
Independent Director |
29/04/2026 |
| Mr. Peter M. Wilver |
Independent Director |
29/04/2026 |
| Mr. William A. Kozy |
Chairman of the Board |
29/04/2026 |
| Mr. Todd C. Schermerhorn |
Independent Director |
29/04/2026 |
| Ms. Stacy Enxing Seng |
Independent Director |
29/04/2026 |
| Mr. Francesco Bianchi |
Independent Director |
29/04/2026 |
| Ms. Susan M. Podlogar |
Independent Director |
29/04/2026 |
| Mr. James Christopher Barry |
Independent Director |
29/04/2026 |
| Ms. Brooke Story |
Independent Director |
29/04/2026 |
| Mr. Vladimir A. Makatsaria |
Chief Executive Officer and Director |
29/04/2026 |
| Ms. Jette Nygaard-Andersen |
Independent Director |
11/06/2026 |
|
|
|
|
